4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001662426-26-000004
Director acquired 2,954 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Morrison Scott W Director | 2026-06-12 | Option exercise | +2,954 | 7,638 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Morrison Scott W Director | 2026-06-12 | Option exercise · Restricted Stock Units | −2,954 | 0 | D: show line 2 in the form |
Loading xslF345X06/wk-form4_1781640402.xml…